NEW YORK, NY--(Marketwire - July 15, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) today announced that CEO Richard L. Taney will appear on FOX Business Network (FBN) to discuss the Company's proprietary Percutaneous Hepatic Perfusion (PHP) System, which is designed to deliver targeted high doses of therapeutic and chemotherapeutic agents. The PHP System is currently being tested in Phase III and II clinical trials for the treatment of hepatocellular carcinoma and metastatic tumors in the liver. Also appearing on this segment will be Dr. James Pingpank of the National Cancer Institute in Bethesda, Maryland. Dr. Pingpank is the Principal Investigator for the Company's ongoing pivotal Phase III trial of metastatic melanoma in the liver. Mr. Taney will discuss the health industry's efforts towards treating cancer on a regionalized basis and provide an update on current approaches to the treatment of liver cancer, including Delcath's PHP System. Mr. Taney will be featured on the "Money for Breakfast" segment on Wednesday, July 16, 2008 to be broadcast at 7:30 AM/ET.
